Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Bobwinson May 09, 2013 11:35am

217 Views

Post# 21357547

RE: SERNOVA PROVIDES CORPORATE UPDATE

"We are continuing to enroll patients in this clinical study of Sernova's Cell Pouch(TM) and we expect to announce the first interim analysis of the data in the second half of 2013," said Dr. James Shapiro MD, Ph.D. FRCS"

Disappointed that analysis has been delayed but 2nd half of 2013 isn't that far away....

I still think they are having issues with finding the right patients, otherwise why are they still enrolling patients almost a year after they started the study?

I'm not being critical of the company but the more patients enrolled in the study, the better. Statistical analysis doesn't work well with very few patients and the study was only supposed to have 20 to begin with, right?

Bullboard Posts

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle